Abstract
Age-related retinal degeneration is associated with mitochondrial dysfunction. Emerging evidence suggests that photobiomodulation therapy (PBMT) using near-infrared light may improve mitochondrial function and visual performance, but its efficacy is critically time-dependent. This article explores how daily biological rhythms and mitochondrial function interact, focusing on the potential of timed PMBT for age-related eye diseases. Further research is needed to determine optimal treatment times and individual responses to maximize this therapy’s benefits.
Get full access to this article
View all access options for this article.
